Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Molecular Screening for Cancer Treatment Optimization (MOSCATO 02)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01566019
Recruitment Status : Recruiting
First Posted : March 29, 2012
Last Update Posted : February 17, 2020
Information provided by (Responsible Party):
Gustave Roussy, Cancer Campus, Grand Paris

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 2020
Estimated Study Completion Date : October 2020
Publications automatically indexed to this study by Identifier (NCT Number):